Combizym compositum, created in 1970 (Germany), from 223 sister brands and 17477 competing brands. The Combizym compositum brand is owned by Daiichi Sankyo, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3475350009. Combizym compositum belongs to the Drug Manufacturers business sector.

Combizym compositum is a brand of Daiichi Sankyo (D4S) Share price

Share price and profitability of the share Daiichi Sankyo (Combizym compositum)

Buy Daiichi Sankyo share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 32.36

Portfolio valuation
Daiichi Sankyo (Combizym compositum) over 5 years* EUR 72.81

Stock market history Daiichi Sankyo (Combizym compositum)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more